This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Nick Lench, Ph.D.
Executive Director at The MRC Nucleic Acid Therapy Accelerator
Speaker

Profile

Nick is Executive Director of the Nucleic Acid Therapy Accelerator, a new MRC Unit based on the Harwell Research Campus. Nick has over 35 years’ experience of working in the genetics of rare disease in academia, the NHS and start-ups and translating research and innovation into clinical service delivery.

Agenda Sessions

  • An Update on the Mission, Goals and Progress of the UK Nucleic Acid Therapy Accelerator

    08:05